191 related articles for article (PubMed ID: 23484707)
1. [Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance].
Zhu Y; Zhuang Y; Yang GH; Qiang XF; Yang L; Shen YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):135-9. PubMed ID: 23484707
[TBL] [Abstract][Full Text] [Related]
2. FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt.
Eyada TK; Farawela HM; Khorshied MM; Shaheen IA; Selim NM; Khalifa IA
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):64-8. PubMed ID: 22123287
[TBL] [Abstract][Full Text] [Related]
3. FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome.
Papagianni A; Economou M; Tragiannidis A; Karatza E; Samarah F; Gombakis N; Athanassiadou-Piperopoulou F; Vavatsi-Christaki N; Athanassiou-Metaxa M
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):35-9. PubMed ID: 23249566
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura.
Fujimoto TT; Inoue M; Shimomura T; Fujimura K
Br J Haematol; 2001 Oct; 115(1):125-30. PubMed ID: 11722422
[TBL] [Abstract][Full Text] [Related]
5. The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura.
Ellithy HN; Ahmed SH; Shahin GH; Matter MM; Talatt M
Hematology; 2018 Apr; 23(3):169-174. PubMed ID: 28856973
[TBL] [Abstract][Full Text] [Related]
6. FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy.
Tanaka Y; Suzuki Y; Tsuge T; Kanamaru Y; Horikoshi S; Monteiro RC; Tomino Y
Nephrol Dial Transplant; 2005 Nov; 20(11):2439-45. PubMed ID: 16221721
[TBL] [Abstract][Full Text] [Related]
7. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.
Carcao MD; Blanchette VS; Wakefield CD; Stephens D; Ellis J; Matheson K; Denomme GA
Br J Haematol; 2003 Jan; 120(1):135-41. PubMed ID: 12492589
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms.
Galimberti S; Palumbo GA; Caracciolo F; Benedetti E; Pelosini M; Brizzi S; Ciabatti E; Fazzi R; Stelitano C; Quintana G; Conte E; Tibullo D; Di Raimondo F; Petrini M
J Chemother; 2007 Jun; 19(3):315-21. PubMed ID: 17594928
[TBL] [Abstract][Full Text] [Related]
9. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
Cooper N; Stasi R; Cunningham-Rundles S; Cesarman E; McFarland JG; Bussel JB
Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462
[TBL] [Abstract][Full Text] [Related]
10. FcγRIIa and FcγRIIIa genes polymorphism in Egyptian children with primary immune thrombocytopenia.
Zakaria M; Al-Akhras A; Hassan T; Sherief L; Magdy W; Raafat N
Hematol Transfus Cell Ther; 2023; 45(1):58-65. PubMed ID: 34266810
[TBL] [Abstract][Full Text] [Related]
11. Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
Boero S; Morabito A; Banelli B; Cardinali B; Dozin B; Lunardi G; Piccioli P; Lastraioli S; Carosio R; Salvi S; Levaggi A; Poggio F; D'Alonzo A; Romani M; Del Mastro L; Poggi A; Pistillo MP
J Transl Med; 2015 Oct; 13():324. PubMed ID: 26450443
[TBL] [Abstract][Full Text] [Related]
12. Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases.
Ozturk C; Aksu G; Berdeli A; Kutukculer N
Clin Exp Med; 2006 Mar; 6(1):27-32. PubMed ID: 16550341
[TBL] [Abstract][Full Text] [Related]
13. FC gamma receptor polymorphisms in patients with immune thrombocytopenia.
Pavkovic M; Petlichkovski A; Karanfilski O; Cevreska L; Stojanovic A
Hematology; 2018 Apr; 23(3):163-168. PubMed ID: 28942727
[TBL] [Abstract][Full Text] [Related]
14. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behçet's disease: do they have any clinical implications?
Aksu K; Kitapcioglu G; Keser G; Berdeli A; Karabulut G; Kobak S; Ozmen M; Inal V; Kabasakal Y; Oksel F; Kocanaogullari H; Doganavsargil E
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S77-83. PubMed ID: 19026120
[TBL] [Abstract][Full Text] [Related]
15. Fcγ receptor gene polymorphisms in childhood immune thrombocytopenic purpura.
Amorim DM; Silveira Vda S; Scrideli CA; Queiroz RG; Tone LG
J Pediatr Hematol Oncol; 2012 Jul; 34(5):349-52. PubMed ID: 22713706
[TBL] [Abstract][Full Text] [Related]
16. FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients.
Yun HR; Koh HK; Kim SS; Chung WT; Kim DW; Hong KP; Song GG; Chang HK; Choe JY; Bae SC; Salmon JE; Yoo DH; Kim TY; Kim SY
Lupus; 2001; 10(7):466-72. PubMed ID: 11480843
[TBL] [Abstract][Full Text] [Related]
17. Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.
Edberg JC; Langefeld CD; Wu J; Moser KL; Kaufman KM; Kelly J; Bansal V; Brown WM; Salmon JE; Rich SS; Harley JB; Kimberly RP
Arthritis Rheum; 2002 Aug; 46(8):2132-40. PubMed ID: 12209518
[TBL] [Abstract][Full Text] [Related]
18. Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.
Hatjiharissi E; Hansen M; Santos DD; Xu L; Leleu X; Dimmock EW; Ho AW; Hunter ZR; Branagan AR; Patterson CJ; Kortsaris A; Verselis S; Fox E; Treon SP
Clin Lymphoma Myeloma; 2007 Jan; 7(4):286-90. PubMed ID: 17324336
[TBL] [Abstract][Full Text] [Related]
19. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.
Pehlivan M; Okan V; Sever T; Balci SO; Yilmaz M; Babacan T; Pehlıvan S
Platelets; 2011; 22(8):588-95. PubMed ID: 21591983
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.
Treon SP; Hansen M; Branagan AR; Verselis S; Emmanouilides C; Kimby E; Frankel SR; Touroutoglou N; Turnbull B; Anderson KC; Maloney DG; Fox EA
J Clin Oncol; 2005 Jan; 23(3):474-81. PubMed ID: 15659493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]